Efficacy Study of IM Administered CssBA+dmLT Against Moderate-severe Diarrhea in Human Infection Model With ETEC Strain B7A in Healthy Adults

NCT06692907 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

NIH

Sponsor class

Conditions

Escherichia Infection

Interventions

OTHER: B7A (ETEC challenge strain)
BIOLOGICAL: CssBA
BIOLOGICAL: dmLT
OTHER: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)